Welcome to our dedicated page for COGNEX SEC filings (Ticker: CGNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cognex Corporation filings document regulatory disclosures for an operating company focused on industrial machine vision products and automation technology. Its Form 8-K reports cover furnished operating results, quarterly cash dividends, share repurchase authorization, board and officer matters, annual meeting voting results, and changes in the company’s independent registered public accounting firm.
Proxy materials describe director elections, governance matters, executive compensation, shareholder voting procedures, and board committee oversight. The filing record also includes exhibit-based disclosures tied to financial-results releases and capital-return actions involving Cognex common stock.
Cognex Corporation vice president and principal accounting officer Laura Ann Macdonald reported routine equity compensation activity. On February 20, 2026 and February 21, 2026, restricted stock units converted into 1,902 and 2,754 shares of common stock, respectively, through derivative exercises at a stated price of $0.00 per share.
To satisfy tax withholding obligations on these vestings, 559 and 809 common shares were automatically withheld at $56.03 per share, as described in the footnotes. Following these transactions, Macdonald directly held 7,211 Cognex common shares, along with multiple non-qualified stock option and restricted stock unit positions. An additional 20 common shares are held indirectly by her child, with beneficial ownership disclaimed except for any pecuniary interest.
Cognex Corporation executive Sheila Marie DiPalma, EVP of Employee Services, reported the vesting of restricted stock units and related tax withholding transactions. On February 20, 2026 and February 21, 2026, she acquired a total of 9,098 shares of common stock through exercises of restricted stock units, each unit converting into one share.
To cover tax withholding obligations on these vested awards, 1,117 shares on February 20, 2026 and 1,555 shares on February 21, 2026 were disposed of at $56.03 per share, as share-withholding rather than open-market sales. After these transactions, she directly owned 15,013 shares of Cognex common stock.
Cognex insider filing reports an intended sale of 10,532 shares of common stock under Rule 144. The filing lists aggregate value $590,107.96 and states shares outstanding were 165,707,920 as of 02/23/2026.
The excerpt also reports prior 10b5-1 sales by Carl W. Gerst III on 02/20/2026 of 3,804 shares for $212,979.49. Timing and method for the 10,532-share disposition are set out in the notice.
Company CGNX reported insider sale activity via a Form 144 notice. The filing lists 61,900 common shares and an aggregate amount of $3,468,385.93 tied to 02/20/2026 on NASDAQ. The excerpt also shows 2,729 restricted shares dated 02/18/2026 and 59,171 shares from a stock option exercise dated 02/20/2026.
COGNEX CORP director Dianne M. Parrotte reported equity award activity involving restricted stock units and common shares. On February 18, 2026, she exercised or converted 8,324 restricted stock units into 8,324 shares of Cognex common stock at a stated price of $0.00 per share, increasing her direct common stock holdings to 30,518 shares.
The filing also lists updated direct holdings of several non-qualified stock options with rights to buy 7,500, 18,400 and 18,100 shares, and 2,913 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Cognex common stock and vests 100% on the first anniversary of the grant date, stated as February 18, 2025.
COGNEX CORP CEO & President Matthew Moschner reported equity awards and vesting activity. On February 18, 2026, 5,085 restricted stock units converted into common stock, with 1,600 shares withheld at $56.7200 per share to satisfy tax withholding obligations.
On February 17, 2026, he received 58,744 non-qualified stock options at an exercise price of $57.0900 and 56,928 restricted stock units, which vest over future anniversaries of the grant date. Following these events he directly holds 93,874 restricted stock units, 11,847 common shares, and options for 697,280 shares.
Cognex Corporation senior vice president and chief financial officer Dennis Fehr reported several equity compensation movements. On February 17, 2026, he was granted 25,306 non-qualified stock options and 24,523 restricted stock units, both at a price of $0.00 per unit. The options vest in five approximately equal annual installments beginning one year after the grant date, while the restricted stock units vest 20%, 30%, and 50% over three years.
On February 18, 2026, 5,085 restricted stock units were converted into the same number of common shares, and 1,618 common shares were disposed of to satisfy tax withholding obligations at $56.72 per share. Following these transactions, Fehr directly owned 14,196 common shares and held 20,339 restricted stock units, along with substantial option holdings.
COGNEX CORP director Angelos Papadimitriou reported equity awards and conversions. On February 18, 2026, he exercised 8,324 restricted stock units at $0.0000 per share into the same number of common shares, bringing his direct common stock holdings to 17,835 shares. On February 17, 2026, he received a grant of 4,817 restricted stock units, which each represent a contingent right to one Cognex common share and vest 100% on the first anniversary of the grant date.